US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

103.63

+0.63000.61%

Volume:410.78K

Turnover:42.59M

Market Cap:5.05B

PE:-17.29

High:104.35

Open:103.74

Low:102.65

Close:103.00

Loading ...

Overview Company News Filings

Axsome Therapeutics Announces Topline Results of Paradigm Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (Mdd) With and Without Excessive Daytime Sleepiness (Eds)

THOMSON REUTERS

Axsome Therapeutics: Results Support Continued Development in Mdd With Concomitant Eds; Phase 3 Trial Planned in 2025

THOMSON REUTERS

Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)

Axsome Therapeutics Is Maintained at Outperform by Mizuho

Axsome Therapeutics Inc : Mizuho Raises Target Price to $216 From $212

THOMSON REUTERS

Mizuho Securities Adjusts Axsome Therapeutics Price Target to $216 From $212, Maintains Outperform Rating

MT Newswires Live

Buy Rating Affirmed for Axsome Therapeutics Amid Promising ADHD Treatment Results and Strategic Market Positioning

Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint

Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating

Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint

MT Newswires Live

BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint

Axsome Therapeutics' ADHD drug meets main goal in late-stage study

Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials

THOMSON REUTERS

Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint

THOMSON REUTERS

Axsome Therapeutics Inc: Statistically Significant Reduction in Overall Adhd Disease Severity as Measured by CGI-S Score Compared to Placebo

THOMSON REUTERS

Strong Growth and Positive Outlook for Axsome Therapeutics’ Auvelity Drives Buy Rating

Strong Market Performance and Growth Potential of Auvelity Drives Positive Outlook for Axsome Therapeutics

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock rises 5.8% this past week

Simply Wall St.

Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AXSM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics","latestPrice":103.63,"timestamp":1745341299469,"preClose":103,"halted":0,"volume":410779,"delay":0,"floatShares":36674187,"shares":48765403,"eps":-5.994374,"marketStatus":"Trading","change":0.63,"latestTime":"04-22 13:01:49 EDT","open":103.74,"high":104.345,"low":102.65,"amount":42587492.28605,"amplitude":0.016456,"askPrice":103.78,"askSize":1,"bidPrice":103.54,"bidSize":634,"shortable":3,"etf":0,"ttmEps":-5.994374,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":103,"preHourTrading":{"tag":"盘前","latestPrice":103.68,"preClose":103,"latestTime":"09:28 EDT","volume":3939,"amount":407105.30055000004,"timestamp":1745328480010},"postHourTrading":{"tag":"盘后","latestPrice":103,"preClose":103,"latestTime":"18:16 EDT","volume":35079,"amount":3613193.23,"timestamp":1745273804350},"volumeRatio":1.132163,"impliedVol":0.5696,"impliedVolPercentile":0.728},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","floatShares":36674187,"roa":"-27.28%","roe":"-231.63%","lyrEps":-5.994374,"volumeRatio":1.132163,"shares":48765403,"dividePrice":0,"high":104.345,"amplitude":0.016456,"preClose":103,"low":102.65,"week52Low":64.11,"pbRate":"88.64","psRate":"13.10","week52High":139.1299,"institutionHeld":0,"latestPrice":103.63,"committee":0.996262,"eps":-5.994374,"divideRate":0,"volume":410779,"delay":0,"ttmEps":-5.994374,"open":103.74,"prevYearClose":84.61,"prevWeekClose":104.46,"prevMonthClose":116.63,"prevQuarterClose":116.63,"fiveDayClose":103.53,"twentyDayClose":129.17,"sixtyDayClose":103.11,"earningDate":1746374400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXSM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524889194","title":"Axsome Therapeutics Announces Topline Results of Paradigm Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (Mdd) With and Without Excessive Daytime Sleepiness (Eds)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524889194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524889194?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4007","BK4585","AXSM"],"gpt_icon":0},{"id":"2524119488","title":"Axsome Therapeutics: Results Support Continued Development in Mdd With Concomitant Eds; Phase 3 Trial Planned in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524119488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524119488?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505309,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nFWN3QF0MU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","AXSM","BK4007"],"gpt_icon":0},{"id":"2524619454","title":"Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524619454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524619454?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505200,"startTime":"0","endTime":"0","summary":"Results support continued development in MDD with concomitant EDS; Phase 3 trial planned in 2025 Approximately 50 percent of MDD patients experience EDS1, highlighting high unmet need NEW YORK, April ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053170/33090/en/Axsome-Therapeutics-Announces-Topline-Results-of-PARADIGM-Phase-3-Proof-of-Concept-Trial-of-Solriamfetol-in-Major-Depressive-Disorder-MDD-with-and-without-Excessive-Daytime-Sleepin.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","BK4505","BK4585","BK4139","BK4215","BK4588","PACI.U","ADHD","BK4597","ESS","ABVC","BK4007","AXSM"],"gpt_icon":0},{"id":"2522308125","title":"Axsome Therapeutics Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2522308125","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522308125?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:48","pubTimestamp":1743079680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 08:48 ET (12:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","MFG"],"gpt_icon":0},{"id":"2522932721","title":"Axsome Therapeutics Inc : Mizuho Raises Target Price to $216 From $212","url":"https://stock-news.laohu8.com/highlight/detail?id=2522932721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522932721?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:34","pubTimestamp":1743071690,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","AXSM","BK4007","BK4505"],"gpt_icon":0},{"id":"2522872000","title":"Mizuho Securities Adjusts Axsome Therapeutics Price Target to $216 From $212, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522872000","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522872000?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:17","pubTimestamp":1742991442,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) has an average rating of Buy and mean price target of $176.63, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","AXSM"],"gpt_icon":0},{"id":"2522845871","title":"Buy Rating Affirmed for Axsome Therapeutics Amid Promising ADHD Treatment Results and Strategic Market Positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2522845871","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522845871?lang=en_us&edition=fundamental","pubTime":"2025-03-26 16:35","pubTimestamp":1742978128,"startTime":"0","endTime":"0","summary":"Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) and increased the pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-axsome-therapeutics-amid-promising-adhd-treatment-results-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-axsome-therapeutics-amid-promising-adhd-treatment-results-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","ADHD","ABVC"],"gpt_icon":0},{"id":"2522039881","title":"Axsome Therapeutics announces FOCUS Phase 3 trial achieved primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522039881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522039881?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:57","pubTimestamp":1742929045,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) announced that the FOCUS Phase 3 trial of solriamfetol in the treatment of attention deficit hyperactivity disorder achi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-announces-focus-phase-3-trial-achieved-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","BK4585","BK4505","BK4007"],"gpt_icon":0},{"id":"2522885337","title":"Axsome Therapeutics’ Promising Phase III FOCUS Trial Results Boost Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522885337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522885337?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:35","pubTimestamp":1742916935,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on AXSM stock, giving a Buy rating today. Myles Minter’s rating is based on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-promising-phase-iii-focus-trial-results-boost-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","III"],"gpt_icon":0},{"id":"2522021437","title":"Axsome Therapeutics' Phase 3 Trial of Solriamfetol to Treat ADHD Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021437","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021437?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903124,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Tuesday that the phase 3 trial of solriamfetol as a potential treatment for attention deficit hyperactivity disorder achieved its primary and key secondary endpoints, demonstrating \"statistically significant\" improvement in symptoms and disease severity.The study met its primary endpoint of a statistically significant reduction in the Adult ADHD Investigator Symptom Rating Scale compared with placebo at week six. The study also achieved the key secondary endpoint of a significant reduction in overall ADHD disease severity, Axsome added.Solriamfetol was also well-tolerated in the study, with no serious adverse events reported, according to Axsome.Axsome Chief Executive Officer Herriot Tabuteau said the company plans to start a solriamfetol trial in pediatric patients this year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ABVC","BK4007","BK4505","ADHD","BK4585","AXSM"],"gpt_icon":0},{"id":"2522021451","title":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522021451","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522021451?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:45","pubTimestamp":1742903113,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary EndpointMarch 25 (Reuters) - Axsome Therapeutics","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM","BK4585","BK4007","BK4505"],"gpt_icon":0},{"id":"2522023160","title":"Axsome Therapeutics' ADHD drug meets main goal in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023160?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:09","pubTimestamp":1742900972,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics' ADHD drug meets main goal in late-stage studyMarch 25  - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder  met the main goal in a late-stage study.    ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3N3Q80OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4505","BK4585","AXSM"],"gpt_icon":0},{"id":"2522702382","title":"Axsome Therapeutics Inc: Well Tolerated With Safety Profile Generally Consistent With Prior Solriamfetol Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2522702382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522702382?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","AXSM","BK4505"],"gpt_icon":0},{"id":"2522028022","title":"Axsome Therapeutics Announces Focus Phase 3 Trial of Solriamfetol in Adults With Attention Deficit Hyperactivity Disorder (Adhd) Achieves Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522028022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522028022?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","AXSM","BK4007","BK4505"],"gpt_icon":0},{"id":"2522023849","title":"Axsome Therapeutics Inc: Statistically Significant Reduction in Overall Adhd Disease Severity as Measured by CGI-S Score Compared to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2522023849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522023849?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:03","pubTimestamp":1742900595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q804P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4505","BK4585","AXSM"],"gpt_icon":0},{"id":"2522033331","title":"Strong Growth and Positive Outlook for Axsome Therapeutics’ Auvelity Drives Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522033331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522033331?lang=en_us&edition=fundamental","pubTime":"2025-03-25 08:25","pubTimestamp":1742862325,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating on March 21. Graig Suvannavejh h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-growth-and-positive-outlook-for-axsome-therapeutics-auvelity-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-growth-and-positive-outlook-for-axsome-therapeutics-auvelity-drives-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2521785870","title":"Strong Market Performance and Growth Potential of Auvelity Drives Positive Outlook for Axsome Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2521785870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521785870?lang=en_us&edition=fundamental","pubTime":"2025-03-24 02:15","pubTimestamp":1742753723,"startTime":"0","endTime":"0","summary":"Vikram Purohit, an analyst from Morgan Stanley, maintained the Buy rating on Axsome Therapeutics (AXSM – Research Report). The associated price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-market-performance-and-growth-potential-of-auvelity-drives-positive-outlook-for-axsome-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-market-performance-and-growth-potential-of-auvelity-drives-positive-outlook-for-axsome-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","BK4516","BK4534","LU1668664300.SGD","BK4505","BK4127","LU0006306889.USD","LU0314104364.USD","LU1720051108.HKD","BK4585","LU0267386448.USD","LU0098860793.USD","LU1732800096.USD","LU2089283258.USD","LU1363072403.SGD","LU1720051017.SGD","LU2357305700.SGD","LU1074936037.SGD","LU2133065610.SGD","LU1989772840.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU0158827948.USD","LU2089284900.SGD","LU0320765646.SGD","IE00BKVL7J92.USD","LU0106261372.USD","LU2028103732.USD","LU0158827781.USD","BK4007","BK4588","LU0912757837.SGD","AXSM","LU2023251221.USD","LU1548497426.USD","LU1989772923.USD","LU1732799900.SGD","LU2271345857.HKD","LU2347655156.SGD","LU0795875169.SGD","LU0225283273.USD","BK4581","LU0106831901.USD"],"gpt_icon":0},{"id":"2520199470","title":"HRMY Down 10.8% in Six Months: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199470","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199470?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:14","pubTimestamp":1742400840,"startTime":"0","endTime":"0","summary":"Shares of Harmony Biosciences HRMY have lost 10.8% in the past six months compared with the industry’s decline of 9.7%. The stock has also underperformed the S&P 500 index during this timeframe.The stock was hit last month after the company announced that it received a Refusal to File  letter from the FDA for pitolisant for the treatment of excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Nonetheless, the fourth-quarter results reported on Feb. 25 were better-than-expected and shares recovered a bit.Let’s dig deeper and understand the company’s strengths and weaknesses in detail to understand how to play the stock in such a scenario.HRMY’s Efforts to Expand Wakix’s Label Suffer Setback. The company was looking to expand the drug’s label for EDS in adult patients with IH. The supplemental new drug application  for pitolisant in IH was submitted in the fourth quarter based on data from the INTUNE study and additional sources.The company targets to initiate a p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-down-10-8-six-161400902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","BK4085","LU0889565916.HKD","FXS","IE00BN0W2W23.USD","BK4563","BK4007","IE00BN0W2T93.GBP","BK4585","LU0320765992.SGD","AXSM","BK4532","BK4510","HRMY","BK4533","IH","JAZZ","IE00BN0W2V16.EUR","LU0109394709.USD","BK4505"],"gpt_icon":0},{"id":"2520938623","title":"Axsome Therapeutics' (NASDAQ:AXSM) growing losses don't faze investors as the stock rises 5.8% this past week","url":"https://stock-news.laohu8.com/highlight/detail?id=2520938623","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520938623?lang=en_us&edition=fundamental","pubTime":"2025-03-18 23:32","pubTimestamp":1742311922,"startTime":"0","endTime":"0","summary":"It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-therapeutics-nasdaqaxsm-growing-losses-dont-faze-inve-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AXSM","PSQ","TQQQ","LU2210150020.SGD","BK4585","BK4007","IE00B3QW5Z07.USD","QID","IE00BGHQF748.EUR","MNQmain","LU2095319765.USD","BK4505","QLD","SQQQ","NQmain","NDAQ","USJW.SI","USAW.SI","IE00B64PRP62.GBP","NVIW.SI","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","TSYW.SI","BK4112",".IXIC"],"gpt_icon":1},{"id":"2519633827","title":"Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519633827","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519633827?lang=en_us&edition=fundamental","pubTime":"2025-03-14 22:55","pubTimestamp":1741964100,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics’ AXSM Auvelity  was launched in the United States in 2022 for the treatment of major depressive disorder , making it the first approved drug in the company’s portfolio.Auvelity generated sales worth $291.4 million in 2024, reflecting an increase of 124% year over year in the United States. Sales of the drug are being driven by an increase in unit sales volume and the momentum is likely to continue in 2025.Axsome is also working to expand the label of Auvelity for the larger commercial opportunity in other central nervous system  disorders like Alzheimer’s disease  agitation and smoking cessation.The successful development and potential approval of Auvelity in additional indications will help the drug address a broader patient population and drive sales further.Axsome is evaluating Sunosi in separate phase III studies for treating attention deficit hyperactivity disorder , MDD, binge eating disorder and excessive sleepiness associated with shift work disorder.Top-lin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/auvelity-other-drugs-aid-axsms-145500596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU0823416689.USD","LU2065170008.USD","BK4505","LU0109394709.USD","JAZZ","BK4139","ADHD","ABVC","BK4135","LU2065171311.SGD","BK4585","BK4532","LU0889565916.HKD","ACAD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","AXSM","BK4533","CNS","LU2065171402.SGD","BK4007","LU2065169927.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXSM\",params:#limit:5,,,undefined,":[{"date":"2025-05-05","symbol":"AXSM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-1.25,"defaultRemindTime":1746432000000,"name":null,"time":"Pre-Market","dateTimestamp":1746417600000,"actualEps":null},{"market":"US","date":"2025-02-18","symbol":"AXSM","fiscalQuarterEnding":"2024/12","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"pre","actualEps":-0.96},{"market":"US","date":"2025-01-13","symbol":"AXSM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"AXSM","fiscalQuarterEnding":"2024/09","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-05","symbol":"AXSM","fiscalQuarterEnding":"2024/06","expectedEps":-1.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":18,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AXSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AXSM","date":"2025-04-21","current":-17.735899,"percent":0.456169,"low":-53.536666,"twenty":-24.181151,"median":-16.742979,"eighty":-12.087351,"high":-6.009438,"avg":-18.8638,"sd":8.815308,"marketCap":5094033997},"quantilePoints":[{"date":"2020-04-24","current":-41.444942,"twenty":-22.708614,"median":-8.903323,"eighty":-3.325117,"marketCap":2832562240},{"date":"2020-05-01","current":-48.893097,"twenty":-22.842924,"median":-8.988352,"eighty":-3.33802,"marketCap":3341607784},{"date":"2020-05-08","current":-47.721355,"twenty":-22.969775,"median":-9.013947,"eighty":-3.3411,"marketCap":3261524873},{"date":"2020-05-15","current":-47.130723,"twenty":-23.061156,"median":-9.035407,"eighty":-3.3411,"marketCap":3221158014},{"date":"2020-05-22","current":-43.886688,"twenty":-23.112438,"median":-9.081016,"eighty":-3.3411,"marketCap":2999443869},{"date":"2020-05-29","current":-41.760164,"twenty":-23.194936,"median":-9.081073,"eighty":-3.3411,"marketCap":2854106169},{"date":"2020-06-05","current":-41.977156,"twenty":-23.271382,"median":-9.08113,"eighty":-3.3411,"marketCap":2868936546},{"date":"2020-06-12","current":-39.20508,"twenty":-23.309919,"median":-9.109467,"eighty":-3.3411,"marketCap":2679478472},{"date":"2020-06-19","current":-43.159764,"twenty":-23.388867,"median":-9.173679,"eighty":-3.34216,"marketCap":2949762104},{"date":"2020-06-26","current":-46.539419,"twenty":-23.453022,"median":-9.194644,"eighty":-3.347892,"marketCap":3180745235},{"date":"2020-07-02","current":-43.924662,"twenty":-23.537303,"median":-9.195895,"eighty":-3.355422,"marketCap":3002039185},{"date":"2020-07-10","current":-45.047597,"twenty":-23.575997,"median":-9.252351,"eighty":-3.360692,"marketCap":3078786389},{"date":"2020-07-17","current":-44.293549,"twenty":-23.688243,"median":-9.27672,"eighty":-3.360692,"marketCap":3027250827},{"date":"2020-07-24","current":-41.960882,"twenty":-23.79365,"median":-9.359006,"eighty":-3.361445,"marketCap":2867824268},{"date":"2020-07-31","current":-38.695148,"twenty":-23.90843,"median":-9.369936,"eighty":-3.364772,"marketCap":2644627085},{"date":"2020-08-07","current":-42.351468,"twenty":-24.001264,"median":-9.445345,"eighty":-3.367789,"marketCap":2894518948},{"date":"2020-08-14","current":-31.085393,"twenty":-24.144138,"median":-9.496431,"eighty":-3.374808,"marketCap":2945457014},{"date":"2020-08-21","current":-30.522708,"twenty":-24.239696,"median":-9.535186,"eighty":-3.37804,"marketCap":2892140513},{"date":"2020-08-28","current":-29.987567,"twenty":-24.493059,"median":-9.615634,"eighty":-3.390967,"marketCap":2841433911},{"date":"2020-09-04","current":-26.890832,"twenty":-24.785116,"median":-9.672397,"eighty":-3.390967,"marketCap":2548006738},{"date":"2020-09-11","current":-28.736281,"twenty":-25.060244,"median":-9.751865,"eighty":-3.390967,"marketCap":2722869945},{"date":"2020-09-18","current":-32.12813,"twenty":-25.208723,"median":-9.865391,"eighty":-3.390967,"marketCap":3044260318},{"date":"2020-09-25","current":-30.30629,"twenty":-26.023431,"median":-10.00765,"eighty":-3.390967,"marketCap":2871634167},{"date":"2020-10-02","current":-27.740762,"twenty":-26.53307,"median":-10.090701,"eighty":-3.390967,"marketCap":2628540753},{"date":"2020-10-09","current":-29.354054,"twenty":-27.382689,"median":-10.228673,"eighty":-3.416217,"marketCap":2781406243},{"date":"2020-10-16","current":-29.015656,"twenty":-28.035876,"median":-10.330949,"eighty":-3.42888,"marketCap":2749341774},{"date":"2020-10-23","current":-28.087029,"twenty":-28.082185,"median":-10.398962,"eighty":-3.42888,"marketCap":2661350907},{"date":"2020-10-30","current":-26.092055,"twenty":-28.035876,"median":-10.444372,"eighty":-3.440834,"marketCap":2472319678},{"date":"2020-11-06","current":-25.564895,"twenty":-28.035876,"median":-10.489783,"eighty":-3.440834,"marketCap":2519239799},{"date":"2020-11-13","current":-28.111531,"twenty":-28.035876,"median":-10.687485,"eighty":-3.440834,"marketCap":2770192830},{"date":"2020-11-20","current":-27.452134,"twenty":-28.082185,"median":-10.932533,"eighty":-3.440834,"marketCap":2705213920},{"date":"2020-11-27","current":-28.490495,"twenty":-28.083154,"median":-11.119611,"eighty":-3.45465,"marketCap":2807537031},{"date":"2020-12-04","current":-30.339838,"twenty":-28.091929,"median":-11.258606,"eighty":-3.484182,"marketCap":2989776732},{"date":"2020-12-11","current":-30.059405,"twenty":-28.419132,"median":-11.329873,"eighty":-3.490702,"marketCap":2962142023},{"date":"2020-12-18","current":-29.661493,"twenty":-28.560787,"median":-11.457113,"eighty":-3.490702,"marketCap":2922930612},{"date":"2020-12-24","current":-32.177812,"twenty":-28.75014,"median":-11.558574,"eighty":-3.490702,"marketCap":3170896106},{"date":"2020-12-31","current":-30.874177,"twenty":-28.947976,"median":-11.582928,"eighty":-3.498176,"marketCap":3042432055},{"date":"2021-01-08","current":-29.449273,"twenty":-29.095272,"median":-11.714853,"eighty":-3.516148,"marketCap":2902017859},{"date":"2021-01-15","current":-29.085468,"twenty":-29.198234,"median":-11.798821,"eighty":-3.532002,"marketCap":2866167426},{"date":"2021-01-22","current":-28.289644,"twenty":-29.165155,"median":-11.860918,"eighty":-3.540569,"marketCap":2787744604},{"date":"2021-01-29","current":-25.803642,"twenty":-29.16126,"median":-11.953582,"eighty":-3.54161,"marketCap":2542766646},{"date":"2021-02-05","current":-28.517022,"twenty":-29.142048,"median":-12.324236,"eighty":-3.552989,"marketCap":2810151125},{"date":"2021-02-12","current":-28.282065,"twenty":-29.117759,"median":-12.416899,"eighty":-3.583568,"marketCap":2786997720},{"date":"2021-02-19","current":-27.38771,"twenty":-29.085468,"median":-12.602226,"eighty":-3.590436,"marketCap":2698865406},{"date":"2021-02-26","current":-25.526998,"twenty":-29.049432,"median":-12.694889,"eighty":-3.590436,"marketCap":2515505379},{"date":"2021-03-05","current":-23.635339,"twenty":-29.023526,"median":-12.694889,"eighty":-3.613962,"marketCap":2432090525},{"date":"2021-03-12","current":-24.169696,"twenty":-29.015656,"median":-12.940357,"eighty":-3.730855,"marketCap":2487076269},{"date":"2021-03-19","current":-23.482665,"twenty":-28.846457,"median":-13.52886,"eighty":-3.760079,"marketCap":2416380312},{"date":"2021-03-26","current":-21.534258,"twenty":-28.838588,"median":-13.621523,"eighty":-3.76982,"marketCap":2215888076},{"date":"2021-04-01","current":-20.901753,"twenty":-28.78446,"median":-13.760518,"eighty":-3.76982,"marketCap":2150802910},{"date":"2021-04-09","current":-19.262328,"twenty":-28.770928,"median":-13.971843,"eighty":-3.76982,"marketCap":1982105151},{"date":"2021-04-16","current":-19.425907,"twenty":-28.764865,"median":-14.131173,"eighty":-3.800991,"marketCap":1998937521},{"date":"2021-04-23","current":-19.307504,"twenty":-28.757285,"median":-14.335102,"eighty":-3.816578,"marketCap":1986753718},{"date":"2021-04-30","current":-22.070934,"twenty":-28.740179,"median":-14.508939,"eighty":-3.818526,"marketCap":2271112305},{"date":"2021-05-07","current":-20.793258,"twenty":-28.736281,"median":-14.681183,"eighty":-3.818526,"marketCap":2139638718},{"date":"2021-05-14","current":-22.019873,"twenty":-28.701655,"median":-14.801134,"eighty":-3.818526,"marketCap":2194862183},{"date":"2021-05-21","current":-20.870256,"twenty":-28.655296,"median":-14.864222,"eighty":-3.826319,"marketCap":2080272494},{"date":"2021-05-28","current":-22.883028,"twenty":-28.636775,"median":-14.92072,"eighty":-3.83606,"marketCap":2280898376},{"date":"2021-06-04","current":-23.112951,"twenty":-28.62768,"median":-15.069857,"eighty":-3.849697,"marketCap":2303816314},{"date":"2021-06-11","current":-25.023953,"twenty":-28.565893,"median":-15.2723,"eighty":-3.85749,"marketCap":2494298192},{"date":"2021-06-18","current":-25.3858,"twenty":-28.525855,"median":-15.395896,"eighty":-3.892558,"marketCap":2530365766},{"date":"2021-06-25","current":-27.70388,"twenty":-28.520054,"median":-15.583979,"eighty":-3.962694,"marketCap":2761423665},{"date":"2021-07-02","current":-24.89203,"twenty":-28.501106,"median":-15.829585,"eighty":-4.001321,"marketCap":2481148555},{"date":"2021-07-09","current":-24.620645,"twenty":-28.488077,"median":-16.072993,"eighty":-4.020803,"marketCap":2454097874},{"date":"2021-07-16","current":-20.436794,"twenty":-28.467162,"median":-16.281692,"eighty":-4.296588,"marketCap":2037066545},{"date":"2021-07-23","current":-20.233255,"twenty":-28.441204,"median":-16.586109,"eighty":-4.680907,"marketCap":2016778535},{"date":"2021-07-30","current":-18.314715,"twenty":-28.433613,"median":-16.793478,"eighty":-4.685848,"marketCap":1825545250},{"date":"2021-08-06","current":-19.283408,"twenty":-28.418818,"median":-17.12943,"eighty":-4.706221,"marketCap":1922101152},{"date":"2021-08-13","current":-7.580584,"twenty":-28.417086,"median":-16.637241,"eighty":-4.716408,"marketCap":861409331},{"date":"2021-08-20","current":-7.149492,"twenty":-28.417086,"median":-16.132105,"eighty":-4.716408,"marketCap":812422798},{"date":"2021-08-27","current":-7.958618,"twenty":-28.417086,"median":-15.583979,"eighty":-4.716408,"marketCap":904366752},{"date":"2021-09-03","current":-8.850647,"twenty":-28.417086,"median":-15.2723,"eighty":-4.716408,"marketCap":1005731192},{"date":"2021-09-10","current":-9.082773,"twenty":-28.417086,"median":-14.928377,"eighty":-4.716408,"marketCap":1032108555},{"date":"2021-09-17","current":-9.855422,"twenty":-28.417086,"median":-14.839801,"eighty":-4.716408,"marketCap":1119907494},{"date":"2021-09-24","current":-11.075744,"twenty":-28.417086,"median":-14.51997,"eighty":-4.716408,"marketCap":1258577063},{"date":"2021-10-01","current":-11.36756,"twenty":-28.417086,"median":-14.177504,"eighty":-4.716408,"marketCap":1291737177},{"date":"2021-10-08","current":-10.677813,"twenty":-28.417086,"median":-13.899514,"eighty":-4.716408,"marketCap":1213358725},{"date":"2021-10-15","current":-13.297524,"twenty":-28.417086,"median":-13.602473,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-22","current":-13.297524,"twenty":-28.417086,"median":-13.469961,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-29","current":-12.76695,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":1450754998},{"date":"2021-11-05","current":-13.330685,"twenty":-28.417086,"median":-13.115139,"eighty":-4.716408,"marketCap":1514814309},{"date":"2021-11-12","current":-11.782465,"twenty":-28.417086,"median":-12.97288,"eighty":-4.716408,"marketCap":1479777437},{"date":"2021-11-19","current":-10.744071,"twenty":-28.417086,"median":-12.694889,"eighty":-4.716408,"marketCap":1349364041},{"date":"2021-11-26","current":-11.080198,"twenty":-28.417086,"median":-12.602226,"eighty":-4.716408,"marketCap":1391578782},{"date":"2021-12-03","current":-9.675666,"twenty":-28.417086,"median":-12.509562,"eighty":-4.716408,"marketCap":1215181471},{"date":"2021-12-10","current":-9.94877,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1249480948},{"date":"2021-12-17","current":-10.594014,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1330518174},{"date":"2021-12-23","current":-11.539372,"twenty":-28.417086,"median":-12.235636,"eighty":-4.716408,"marketCap":1449247133},{"date":"2021-12-31","current":-11.338296,"twenty":-28.417086,"median":-11.768255,"eighty":-4.716408,"marketCap":1423993672},{"date":"2022-01-07","current":-9.876742,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1240434933},{"date":"2022-01-14","current":-8.583252,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1077983563},{"date":"2022-01-21","current":-7.114196,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":893482530},{"date":"2022-01-28","current":-7.898993,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":992046412},{"date":"2022-02-04","current":-8.616265,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1082129654},{"date":"2022-02-11","current":-9.621646,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1208396959},{"date":"2022-02-18","current":-8.874363,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1114544544},{"date":"2022-02-25","current":-8.460206,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1062529953},{"date":"2022-03-04","current":-8.825214,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1150834298},{"date":"2022-03-11","current":-9.674984,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1261646828},{"date":"2022-03-18","current":-9.916932,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1293197618},{"date":"2022-03-25","current":-10.433285,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1360531621},{"date":"2022-04-01","current":-12.95604,"twenty":-28.415355,"median":-11.795362,"eighty":-4.726594,"marketCap":1689506320},{"date":"2022-04-08","current":-12.00595,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1565611755},{"date":"2022-04-14","current":-10.875874,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1418246480},{"date":"2022-04-22","current":-11.667797,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1521515699},{"date":"2022-04-29","current":-9.47449,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1235501878},{"date":"2022-05-06","current":-8.242936,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1160402061},{"date":"2022-05-13","current":-7.712204,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1085688045},{"date":"2022-05-20","current":-8.74879,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1231613857},{"date":"2022-05-27","current":-7.314154,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1029652533},{"date":"2022-06-03","current":-7.057081,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":993462931},{"date":"2022-06-10","current":-6.730902,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":947544942},{"date":"2022-06-17","current":-6.272039,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":882948449},{"date":"2022-06-24","current":-6.761308,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":951825433},{"date":"2022-07-01","current":-11.233834,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1581446672},{"date":"2022-07-08","current":-12.604892,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1774457880},{"date":"2022-07-15","current":-12.076924,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1700132999},{"date":"2022-07-22","current":-11.142614,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1568605200},{"date":"2022-07-29","current":-10.667166,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1501673894},{"date":"2022-08-05","current":-12.007818,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1690404612},{"date":"2022-08-12","current":-12.438313,"twenty":-28.417086,"median":-12.604892,"eighty":-4.716408,"marketCap":1864871817},{"date":"2022-08-19","current":-16.008246,"twenty":-28.417086,"median":-12.734015,"eighty":-4.716408,"marketCap":2400110584},{"date":"2022-08-26","current":-19.19834,"twenty":-28.417086,"median":-13.012341,"eighty":-4.716408,"marketCap":2878400274},{"date":"2022-09-02","current":-18.014352,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":2700885345},{"date":"2022-09-09","current":-17.751244,"twenty":-28.417086,"median":-13.297524,"eighty":-4.716408,"marketCap":2661437584},{"date":"2022-09-16","current":-16.93046,"twenty":-28.417086,"median":-13.546231,"eighty":-4.716408,"marketCap":2538377718},{"date":"2022-09-23","current":-14.373731,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":2155048380},{"date":"2022-09-30","current":-12.760762,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":1913216449},{"date":"2022-10-07","current":-13.103947,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1964670051},{"date":"2022-10-14","current":-13.7274,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":2058144096},{"date":"2022-10-21","current":-11.862761,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1778579522},{"date":"2022-10-28","current":-12.102991,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1814597044},{"date":"2022-11-04","current":-16.327026,"twenty":-28.417086,"median":-13.971843,"eighty":-4.716408,"marketCap":2447905134},{"date":"2022-11-11","current":-16.029117,"twenty":-28.417086,"median":-14.373731,"eighty":-4.767341,"marketCap":2562577819},{"date":"2022-11-18","current":-15.257677,"twenty":-28.417086,"median":-14.497908,"eighty":-4.79395,"marketCap":2439247519},{"date":"2022-11-25","current":-15.434239,"twenty":-28.417086,"median":-14.724173,"eighty":-4.898255,"marketCap":2467474524},{"date":"2022-12-02","current":-20.888648,"twenty":-28.417086,"median":-14.896404,"eighty":-4.898255,"marketCap":3339471857},{"date":"2022-12-09","current":-20.334515,"twenty":-28.417086,"median":-14.934267,"eighty":-4.898255,"marketCap":3250882487},{"date":"2022-12-16","current":-21.296099,"twenty":-28.417086,"median":-15.271259,"eighty":-4.898255,"marketCap":3404611100},{"date":"2022-12-23","current":-20.043867,"twenty":-28.417086,"median":-15.412018,"eighty":-4.898255,"marketCap":3204416493},{"date":"2022-12-30","current":-20.951124,"twenty":-28.417086,"median":-15.545609,"eighty":-4.898255,"marketCap":3349459875},{"date":"2023-01-06","current":-18.46839,"twenty":-28.417086,"median":-15.702202,"eighty":-6.20404,"marketCap":2952544754},{"date":"2023-01-13","current":-18.280963,"twenty":-28.417086,"median":-16.029117,"eighty":-6.567519,"marketCap":2922580702},{"date":"2023-01-20","current":-19.23983,"twenty":-28.417086,"median":-16.281692,"eighty":-6.731359,"marketCap":3075875054},{"date":"2023-01-27","current":-19.087715,"twenty":-28.417086,"median":-16.637241,"eighty":-6.946485,"marketCap":3051556403},{"date":"2023-02-03","current":-18.66125,"twenty":-28.417086,"median":-17.062014,"eighty":-7.089998,"marketCap":2983377329},{"date":"2023-02-10","current":-17.055894,"twenty":-28.417086,"median":-17.13163,"eighty":-7.187,"marketCap":2726728711},{"date":"2023-02-17","current":-18.096252,"twenty":-28.417086,"median":-17.237888,"eighty":-7.373862,"marketCap":2893050912},{"date":"2023-02-24","current":-16.583251,"twenty":-28.417086,"median":-17.237888,"eighty":-7.712635,"marketCap":2651167190},{"date":"2023-03-03","current":-15.180365,"twenty":-28.417086,"median":-17.237888,"eighty":-7.893661,"marketCap":2840757185},{"date":"2023-03-10","current":-13.578148,"twenty":-28.417086,"median":-17.237888,"eighty":-8.043265,"marketCap":2540928493},{"date":"2023-03-17","current":-14.589708,"twenty":-28.417086,"median":-17.237888,"eighty":-8.219199,"marketCap":2730225272},{"date":"2023-03-24","current":-14.408325,"twenty":-28.417086,"median":-17.237888,"eighty":-8.347465,"marketCap":2696282401},{"date":"2023-03-31","current":-14.343213,"twenty":-28.415355,"median":-17.237888,"eighty":-8.438189,"marketCap":2684097781},{"date":"2023-04-06","current":-13.582799,"twenty":-28.415355,"median":-17.237888,"eighty":-8.515067,"marketCap":2541798823},{"date":"2023-04-14","current":-15.126881,"twenty":-28.417086,"median":-17.237888,"eighty":-8.590342,"marketCap":2830748390},{"date":"2023-04-21","current":-16.577945,"twenty":-28.417086,"median":-17.237888,"eighty":-8.633548,"marketCap":3102291356},{"date":"2023-04-28","current":-16.560131,"twenty":-28.417086,"median":-17.237888,"eighty":-8.782049,"marketCap":3098957798},{"date":"2023-05-05","current":-16.557804,"twenty":-28.417086,"median":-17.237888,"eighty":-8.912326,"marketCap":3098522307},{"date":"2023-05-12","current":-21.39324,"twenty":-28.417086,"median":-17.328154,"eighty":-9.013947,"marketCap":3395527537},{"date":"2023-05-19","current":-21.103076,"twenty":-28.417086,"median":-17.513874,"eighty":-9.093997,"marketCap":3349472883},{"date":"2023-05-26","current":-18.692708,"twenty":-28.417086,"median":-17.629041,"eighty":-9.135139,"marketCap":2966900073},{"date":"2023-06-02","current":-19.97476,"twenty":-28.417086,"median":-17.77844,"eighty":-9.187407,"marketCap":3170386977},{"date":"2023-06-09","current":-20.655593,"twenty":-28.417086,"median":-17.924982,"eighty":-9.24781,"marketCap":3278448546},{"date":"2023-06-16","current":-23.233424,"twenty":-28.417086,"median":-18.014352,"eighty":-9.337052,"marketCap":3687601016},{"date":"2023-06-23","current":-24.803733,"twenty":-28.418818,"median":-18.297839,"eighty":-9.445345,"marketCap":3936839794},{"date":"2023-06-30","current":-20.073591,"twenty":-28.420549,"median":-18.46839,"eighty":-9.469338,"marketCap":3186073334},{"date":"2023-07-07","current":-20.290469,"twenty":-28.420549,"median":-18.576208,"eighty":-9.560131,"marketCap":3220496172},{"date":"2023-07-14","current":-20.040647,"twenty":-28.420549,"median":-18.698313,"eighty":-9.653222,"marketCap":3180844549},{"date":"2023-07-21","current":-20.433224,"twenty":-28.420549,"median":-18.862469,"eighty":-9.751865,"marketCap":3243154243},{"date":"2023-07-28","current":-21.245831,"twenty":-28.420549,"median":-18.946466,"eighty":-9.838866,"marketCap":3372130954},{"date":"2023-08-04","current":-20.666574,"twenty":-28.420549,"median":-19.022523,"eighty":-9.919098,"marketCap":3280191474},{"date":"2023-08-11","current":-18.037146,"twenty":-28.420549,"median":-19.022523,"eighty":-9.959731,"marketCap":3326963385},{"date":"2023-08-18","current":-17.717339,"twenty":-28.420549,"median":-19.022523,"eighty":-10.057126,"marketCap":3267974672},{"date":"2023-08-25","current":-19.290792,"twenty":-28.420549,"median":-19.061023,"eighty":-10.126968,"marketCap":3558199138},{"date":"2023-09-01","current":-20.672361,"twenty":-28.420549,"median":-19.094946,"eighty":-10.228966,"marketCap":3813030376},{"date":"2023-09-08","current":-20.830985,"twenty":-28.420549,"median":-19.19834,"eighty":-10.246301,"marketCap":3842288777},{"date":"2023-09-15","current":-19.495469,"twenty":-28.420549,"median":-19.262328,"eighty":-10.349328,"marketCap":3595951914},{"date":"2023-09-22","current":-19.119375,"twenty":-28.420549,"median":-19.262328,"eighty":-10.378868,"marketCap":3526581188},{"date":"2023-09-29","current":-18.692112,"twenty":-28.420549,"median":-19.262328,"eighty":-10.440043,"marketCap":3447772268},{"date":"2023-10-06","current":-17.23379,"twenty":-28.420549,"median":-19.262328,"eighty":-10.525456,"marketCap":3178783739},{"date":"2023-10-13","current":-17.016321,"twenty":-28.420549,"median":-19.262328,"eighty":-10.598456,"marketCap":3138671414},{"date":"2023-10-20","current":-16.438109,"twenty":-28.420549,"median":-19.262328,"eighty":-10.646711,"marketCap":3032019822},{"date":"2023-10-27","current":-16.386939,"twenty":-28.429835,"median":-19.282946,"eighty":-10.674305,"marketCap":3022581628},{"date":"2023-11-03","current":-16.476485,"twenty":-28.429835,"median":-19.282946,"eighty":-10.808289,"marketCap":3039098468},{"date":"2023-11-10","current":-14.081381,"twenty":-28.429835,"median":-19.282946,"eighty":-10.929836,"marketCap":2842011992},{"date":"2023-11-17","current":-13.999321,"twenty":-28.429835,"median":-19.282946,"eighty":-11.058288,"marketCap":2825450151},{"date":"2023-11-24","current":-14.665174,"twenty":-28.429835,"median":-19.282946,"eighty":-11.129652,"marketCap":2959837664},{"date":"2023-12-01","current":-15.814005,"twenty":-28.429835,"median":-19.282946,"eighty":-11.282106,"marketCap":3191703445},{"date":"2023-12-08","current":-16.46579,"twenty":-28.426058,"median":-19.282946,"eighty":-11.336853,"marketCap":3323251785},{"date":"2023-12-15","current":-17.178534,"twenty":-28.426058,"median":-19.282946,"eighty":-11.380162,"marketCap":3467103208},{"date":"2023-12-22","current":-16.993315,"twenty":-28.426058,"median":-19.282946,"eighty":-11.419937,"marketCap":3429720766},{"date":"2023-12-29","current":-18.667325,"twenty":-28.429835,"median":-19.282946,"eighty":-11.503011,"marketCap":3767582332},{"date":"2024-01-05","current":-19.222984,"twenty":-28.433613,"median":-19.282946,"eighty":-11.566713,"marketCap":3879729658},{"date":"2024-01-12","current":-20.245209,"twenty":-28.433613,"median":-19.306357,"eighty":-11.683287,"marketCap":4086042883},{"date":"2024-01-19","current":-19.811466,"twenty":-28.43739,"median":-19.389342,"eighty":-11.809472,"marketCap":3998501721},{"date":"2024-01-26","current":-21.239299,"twenty":-28.433613,"median":-19.465893,"eighty":-11.861401,"marketCap":4286677762},{"date":"2024-02-02","current":-21.909841,"twenty":-28.433613,"median":-19.601888,"eighty":-11.983144,"marketCap":4422011667},{"date":"2024-02-09","current":-22.432676,"twenty":-28.433613,"median":-19.675324,"eighty":-12.075057,"marketCap":4527534256},{"date":"2024-02-16","current":-21.912185,"twenty":-28.433613,"median":-19.76274,"eighty":-12.186969,"marketCap":4422484862},{"date":"2024-02-23","current":-15.927086,"twenty":-28.433613,"median":-19.76274,"eighty":-12.293238,"marketCap":3810364180},{"date":"2024-03-01","current":-16.115026,"twenty":-28.429835,"median":-19.739727,"eighty":-12.506682,"marketCap":3855326637},{"date":"2024-03-08","current":-14.265501,"twenty":-28.429835,"median":-19.739727,"eighty":-12.677006,"marketCap":3412849975},{"date":"2024-03-15","current":-13.810051,"twenty":-28.429835,"median":-19.739727,"eighty":-12.869437,"marketCap":3303888912},{"date":"2024-03-22","current":-16.012055,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3830691962},{"date":"2024-03-28","current":-15.677398,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3750629268},{"date":"2024-04-05","current":-14.291244,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3419008643},{"date":"2024-04-12","current":-14.204114,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3398163918},{"date":"2024-04-19","current":-13.014002,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3113443925},{"date":"2024-04-26","current":-14.16253,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3388215300},{"date":"2024-05-03","current":-14.728134,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3523529410},{"date":"2024-05-10","current":-11.807571,"twenty":-28.429835,"median":-19.701371,"eighty":-12.750063,"marketCap":3499492533},{"date":"2024-05-17","current":-12.395706,"twenty":-28.429835,"median":-19.649302,"eighty":-12.578012,"marketCap":3673802218},{"date":"2024-05-24","current":-11.887699,"twenty":-28.429835,"median":-19.525695,"eighty":-12.436014,"marketCap":3523240446},{"date":"2024-05-31","current":-11.892506,"twenty":-28.429835,"median":-19.442778,"eighty":-12.367228,"marketCap":3524665321},{"date":"2024-06-07","current":-11.980646,"twenty":-28.429835,"median":-19.343656,"eighty":-12.253794,"marketCap":3550788026},{"date":"2024-06-14","current":-11.620073,"twenty":-28.433613,"median":-19.298009,"eighty":-12.177866,"marketCap":3443922415},{"date":"2024-06-21","current":-12.047953,"twenty":-28.43739,"median":-19.272637,"eighty":-12.168336,"marketCap":3570736273},{"date":"2024-06-28","current":-12.834804,"twenty":-28.441192,"median":-19.23983,"eighty":-12.143826,"marketCap":3803940784},{"date":"2024-07-05","current":-12.854035,"twenty":-28.441192,"median":-19.19834,"eighty":-12.143826,"marketCap":3809640283},{"date":"2024-07-12","current":-13.549541,"twenty":-28.441192,"median":-19.087715,"eighty":-12.143826,"marketCap":4015772172},{"date":"2024-07-15","current":-13.273902,"twenty":-28.441192,"median":-19.07844,"eighty":-12.143826,"marketCap":3934079350},{"date":"2024-08-02","current":-13.783512,"twenty":-28.490495,"median":-18.952635,"eighty":-12.102991,"marketCap":4085116080},{"date":"2024-08-09","current":-13.223111,"twenty":-28.490495,"median":-18.859161,"eighty":-12.102991,"marketCap":4080017425},{"date":"2024-08-16","current":-13.318007,"twenty":-28.490495,"median":-18.73003,"eighty":-12.102991,"marketCap":4109297550},{"date":"2024-08-23","current":-13.551356,"twenty":-28.490495,"median":-18.673323,"eighty":-12.102991,"marketCap":4181297857},{"date":"2024-08-30","current":-13.862488,"twenty":-28.490495,"median":-18.56764,"eighty":-12.102991,"marketCap":4277298267},{"date":"2024-09-06","current":-14.57498,"twenty":-28.490495,"median":-18.506355,"eighty":-12.102991,"marketCap":4497139206},{"date":"2024-09-13","current":-14.273182,"twenty":-28.490495,"median":-18.365921,"eighty":-12.102991,"marketCap":4404018808},{"date":"2024-09-20","current":-14.672987,"twenty":-28.490495,"median":-18.269068,"eighty":-12.102991,"marketCap":4527379335},{"date":"2024-09-27","current":-13.944938,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4302738376},{"date":"2024-10-04","current":-14.184509,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4376658691},{"date":"2024-10-11","current":-12.924425,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":3987857031},{"date":"2024-10-18","current":-14.522087,"twenty":-28.490495,"median":-18.096122,"eighty":-12.102991,"marketCap":4480819136},{"date":"2024-10-25","current":-13.818929,"twenty":-28.490495,"median":-18.063615,"eighty":-12.102991,"marketCap":4263858210},{"date":"2024-10-31","current":-13.916936,"twenty":-28.490495,"median":-18.025749,"eighty":-12.102991,"marketCap":4294098339},{"date":"2024-11-08","current":-14.109838,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4353618593},{"date":"2024-11-15","current":-15.175127,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4718781551},{"date":"2024-11-22","current":-15.302924,"twenty":-28.4958,"median":-17.88108,"eighty":-12.097778,"marketCap":4758520699},{"date":"2024-11-29","current":-15.307599,"twenty":-28.4958,"median":-17.77844,"eighty":-12.097778,"marketCap":4759974570},{"date":"2024-12-06","current":-15.32786,"twenty":-28.449873,"median":-17.629041,"eighty":-12.097778,"marketCap":4766274679},{"date":"2024-12-13","current":-14.707576,"twenty":-28.320039,"median":-17.452847,"eighty":-12.097778,"marketCap":4573394423},{"date":"2024-12-20","current":-13.98599,"twenty":-28.091929,"median":-17.328154,"eighty":-12.097778,"marketCap":4349013622},{"date":"2024-12-27","current":-13.710136,"twenty":-27.950529,"median":-17.237888,"eighty":-12.097778,"marketCap":4263235216},{"date":"2025-01-03","current":-13.608833,"twenty":-27.778537,"median":-17.194427,"eighty":-12.097778,"marketCap":4231734672},{"date":"2025-01-10","current":-12.868545,"twenty":-27.620773,"median":-17.134813,"eighty":-12.092564,"marketCap":4001538386},{"date":"2025-01-17","current":-14.601598,"twenty":-27.401353,"median":-17.062407,"eighty":-12.092564,"marketCap":4540440007},{"date":"2025-01-24","current":-16.19127,"twenty":-27.316594,"median":-17.006543,"eighty":-12.092564,"marketCap":5034756242},{"date":"2025-01-31","current":-16.964286,"twenty":-27.062663,"median":-16.935586,"eighty":-12.092564,"marketCap":5275129627},{"date":"2025-02-07","current":-17.065589,"twenty":-26.869288,"median":-16.889297,"eighty":-12.092564,"marketCap":5306630172},{"date":"2025-02-14","current":-20.522345,"twenty":-26.613063,"median":-16.886581,"eighty":-12.092564,"marketCap":6381525671},{"date":"2025-02-21","current":-21.919439,"twenty":-26.428477,"median":-16.886581,"eighty":-12.092564,"marketCap":6295613527},{"date":"2025-02-28","current":-21.462713,"twenty":-26.259509,"median":-16.886581,"eighty":-12.092564,"marketCap":6164434593},{"date":"2025-03-07","current":-21.12314,"twenty":-25.773705,"median":-16.884764,"eighty":-12.087351,"marketCap":6066903787},{"date":"2025-03-14","current":-20.654529,"twenty":-25.461185,"median":-16.884764,"eighty":-12.087351,"marketCap":5932311274},{"date":"2025-03-21","current":-21.438943,"twenty":-25.440831,"median":-16.884764,"eighty":-12.087351,"marketCap":6157607436},{"date":"2025-03-28","current":-20.674904,"twenty":-25.12508,"median":-16.884764,"eighty":-12.087351,"marketCap":5938163123},{"date":"2025-04-04","current":-18.318267,"twenty":-24.742094,"median":-16.884764,"eighty":-12.087351,"marketCap":5261299329},{"date":"2025-04-11","current":-16.24008,"twenty":-24.602553,"median":-16.762118,"eighty":-12.092564,"marketCap":4664410796},{"date":"2025-04-17","current":-17.737597,"twenty":-24.358761,"median":-16.744642,"eighty":-12.092564,"marketCap":5094521651},{"date":"2025-04-21","current":-17.735899,"twenty":-24.181151,"median":-16.742979,"eighty":-12.087351,"marketCap":5094033997}],"updateTime":1745317579190}}}